Author Archives: Scalper1

Apple keeping battery-case makers in business with iPhone 6S

Apple (AAPL) improved a lot of features with its latest iPhone, but battery life doesn’t appear to be one of them. Reviews of the iPhone 6S, which is due out Friday, praise the device’s pressure-sensitive screen, faster processor and improved cameras, but some dinged it for not boosting battery life. That’s good news for makers of iPhone cases with auxiliary batteries such as Belkin, Mophie and OtterBox. Such cases typically cost $100 or more.

Amgen, Allergan Biosimilar Avastin Hits In Trial

Big drugmakers Amgen (AMGN) and Allergan (AGN) announced Wednesday that their biosimilar version of Roche’s (RHHBY) blockbuster cancer drug Avastin succeeded in a late-stage trial against non-small-cell lung cancer. Amgen and Allergan, which started their collaboration back in 2011 when Allergan was a generic drug maker called Watson Pharmaceuticals, released few details but said the drug ABP 215 had shown clinical equivalence to Avastin as

Health Care Focus: AmSurg, Mednax Assert Leadership

Distribution days are starting to make their presence felt in the major averages, but the medical sector continues to be a source of leadership. Out of 14 subgroups tracked in the medical sector, five ranked in the top 40 in IBD’s 197 industry group rankings as of Tuesday’s close, including Medical-Outpatient/Home Care. One of the fundamental superstars in the group is Acadia Healthcare (ACHC), but buying demand has dried up as the stock